FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791361443> ?p ?o ?g. }

• W2791361443 endingPage "iii4" @default.
• W2791361443 startingPage "iii3" @default.
• W2791361443 abstract "Background: In cancer the presence of T cell immune infiltration has been recognised as a prognostic factor, however the mechanisms underpinning this response are not clearly defined. Our group and others have identified a relationship between type I Interferon immune signalling and loss of DNA repair, particularly the Fanconi Anemia pathway, in several different types of cancer. We therefore investigated the mechanism activating this immune response in the context of abnormal DNA repair. Methods: Preclinical isogenic cell line systems and human tumours were used to identify the relationship between loss of function of DNA repair genes and activation of immune signalling. A panel of Chemotherapeutic agents were studied for their effect on immune activation. Results: IHC analysis demonstrated that both intra-tumoral and stromal CD8+ and CD4+ T cell infiltration were associated with DNA repair deficient breast tumors. The CXCL10 and CCL5 cytokines as well as the immune checkpoint target PD-L1 were shown to be significantly up-regulated in DNA repair deficient tumours and in tissue culture models when compared to DNA proficent tumours. Furthermore, conditioned media from DNA repair deficient cell lines stimulated inward migration of peripheral blood mononuclear cells, when compared to media from proficient cells, indicating the presence of active cytokines. We identified constitutive activation of the innate immune pathway STING/TBK1/IRF3 specifically in DNA repair deficient tumour cells when compared to proficient cells and found that binding of the DNA sensor cGAS to cytosolic DNA fragments was required for this immune response. In addition, we identified several chemotherapeutic agents that were able to activate the immune response in DNA repair proficient cell lines through DNA damage, the development of cytoplasmic DNA fragments and the consequent activation of the STING/TBK1/IRF3 immune pathway. Conclusions: We have identified that the STING/TBK1/IRF3 immune pathway is constitutively activated by cytoplasmic DNA in DNA repair deficient cancers and may explain lymphocytic infiltration and the response to immune checkpoint based therapy. Some conventional chemotherapy agents such as doxorubicin are able to active this pathway in DNA repair proficient cancers and may represent a logical combination with immune checkpoint targeted drugs in clinical trials. Legal entity responsible for the study: Queen's University of Belfast Funding: McClay Foundation Disclosure: R. Kennedy: I receive payment as the Global VP and Medical Director for Almac Diagnostics." @default.
• W2791361443 created "2018-03-29" @default.
• W2791361443 creator A5088266020 @default.
• W2791361443 date "2018-03-01" @default.
• W2791361443 modified "2023-09-25" @default.
• W2791361443 title "The relationship between DNA damage and immune checkpoint activation in cancer" @default.
• W2791361443 doi "https://doi.org/10.1093/annonc/mdy046.010" @default.
• W2791361443 hasPublicationYear "2018" @default.
• W2791361443 type Work @default.
• W2791361443 sameAs 2791361443 @default.
• W2791361443 citedByCount "0" @default.
• W2791361443 crossrefType "journal-article" @default.
• W2791361443 hasAuthorship W2791361443A5088266020 @default.
• W2791361443 hasBestOaLocation W27913614431 @default.
• W2791361443 hasConcept C134935766 @default.
• W2791361443 hasConcept C143425029 @default.
• W2791361443 hasConcept C203014093 @default.
• W2791361443 hasConcept C502942594 @default.
• W2791361443 hasConcept C54355233 @default.
• W2791361443 hasConcept C552990157 @default.
• W2791361443 hasConcept C71924100 @default.
• W2791361443 hasConcept C86803240 @default.
• W2791361443 hasConcept C8891405 @default.
• W2791361443 hasConceptScore W2791361443C134935766 @default.
• W2791361443 hasConceptScore W2791361443C143425029 @default.
• W2791361443 hasConceptScore W2791361443C203014093 @default.
• W2791361443 hasConceptScore W2791361443C502942594 @default.
• W2791361443 hasConceptScore W2791361443C54355233 @default.
• W2791361443 hasConceptScore W2791361443C552990157 @default.
• W2791361443 hasConceptScore W2791361443C71924100 @default.
• W2791361443 hasConceptScore W2791361443C86803240 @default.
• W2791361443 hasConceptScore W2791361443C8891405 @default.
• W2791361443 hasLocation W27913614431 @default.
• W2791361443 hasOpenAccess W2791361443 @default.
• W2791361443 hasPrimaryLocation W27913614431 @default.
• W2791361443 hasRelatedWork W1491007731 @default.
• W2791361443 hasRelatedWork W2107112594 @default.
• W2791361443 hasRelatedWork W2130814563 @default.
• W2791361443 hasRelatedWork W2138388674 @default.
• W2791361443 hasRelatedWork W2364709831 @default.
• W2791361443 hasRelatedWork W2518520516 @default.
• W2791361443 hasRelatedWork W2774282247 @default.
• W2791361443 hasRelatedWork W2988849705 @default.
• W2791361443 hasRelatedWork W4304891185 @default.
• W2791361443 hasRelatedWork W4319017166 @default.
• W2791361443 hasVolume "29" @default.
• W2791361443 isParatext "false" @default.
• W2791361443 isRetracted "false" @default.
• W2791361443 magId "2791361443" @default.
• W2791361443 workType "article" @default.